In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate
| Date first appeared online | 11/05/2020 |
| DOI | 10.1124/jpet.120.265249 |
| Authors | Austin-Muttitt K., Mullins J. |
| Journal Name | Journal of Pharmacology and Experimental Therapeutics |
| Volume | 374 |